Insider Trading › EYPT › Insiders
EyePoint, Inc.
EYPT·Nasdaq·
United States·Insider activity
$0.44
-2.55 (-85.28%)
Close · Oct 19, 2026 · Close Prices from Tiingo.com
EYPT
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EYPTS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, EYPT insiders filed 1 purchase ($52K) and 2 sales ($73K) on the open market, by 2 insiders. Newest filing Aug 18, 2026 (2 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by EYPT insiders · Form 4 · last two years
On Record
$52KPurchases · 180 days
$73KSales · 180 days
112Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of EYPT common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
112 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Zaderej Karen L.Director | Purchase | +10.6K | $4.93 | $52K | 49.1Kdirect | Aug 18, 2026 | Aug 18, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,438 | $15.02 | $37K | 0direct | Jun 30, 2026 | Jul 2, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,437 | $15.00 | $37K | 2,438direct | Jun 30, 2026 | Jul 2, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,437 | $15.00 | $37K | 0direct | Apr 17, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Purchase | +1,500 | $13.15 | $20K | 100.7Kindirect | Mar 16, 2026 | Mar 16, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,438 | $17.87 | $44K | 0direct | Mar 4, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,437 | $15.00 | $37K | 0direct | Feb 17, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −42.5K | $17.10 | $728K | 0direct | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Cormorant Asset Management, LP | Sale | −60.0K | $15.70 | $942K | 8.3Mindirect | Dec 4, 2025 | Dec 8, 2025 | Form 4 ↗ |
| Lurker NancyDirector | Sale | −9,300 | $15.11 | $141K | 206.5Kdirect | Dec 4, 2025 | Dec 5, 2025 | Form 4 ↗ |
| Lurker NancyDirector | Sale | −500 | $14.95 | $7K | 215.8Kdirect | Nov 28, 2025 | Dec 1, 2025 | Form 4 ↗ |
| Lurker NancyDirector | Sale | −200 | $14.95 | $3K | 216.3Kdirect | Nov 26, 2025 | Dec 1, 2025 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,722 | $11.61 | $32K | 0direct | Nov 11, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +5,000 | $5.99 | $30K | 36.5Kdirect | May 19, 2025 | May 19, 2025 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +5,000 | $5.81 | $29K | 31.5Kdirect | May 16, 2025 | May 19, 2025 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +5,000 | $5.47 | $27K | 26.5Kdirect | May 15, 2025 | May 15, 2025 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +5,000 | $5.42 | $27K | 21.5Kdirect | May 14, 2025 | May 15, 2025 | Form 4 ↗ |
| ANDO GORANDirector | Purchase | +5,000 | $7.95 | $40K | 13.2Kdirect | Aug 21, 2024 | Aug 21, 2024 | Form 4 ↗ |
| DICICCO WENDY FDirector | Purchase | +2,567 | $7.79 | $20K | 9,967direct | Aug 20, 2024 | Aug 21, 2024 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +12.5K | $7.98 | $100K | 16.5Kdirect | Aug 19, 2024 | Aug 21, 2024 | Form 4 ↗ |
| Lurker NancyDirector | Purchase | +3,173 | $7.88 | $25K | 97.6Kdirect | Aug 16, 2024 | Aug 20, 2024 | Form 4 ↗ |
| GUYER DAVID RDirector | Sale | −11.6K | $10.06 | $117K | 1,850direct | Jul 12, 2024 | Jul 16, 2024 | Form 4 ↗ |
| GUYER DAVID RDirector | Sale | −11.6K | $10.30 | $120K | 3,700direct | Jun 3, 2024 | Jun 4, 2024 | Form 4 ↗ |
| GUYER DAVID RDirector | Sale | −11.6K | $12.65 | $147K | 5,550direct | May 14, 2024 | May 16, 2024 | Form 4 ↗ |
| Cormorant Asset Management, LP10% owner | Purchase | +207.2K | $12.36 | $2.6M | 8.3Mindirect | May 6, 2024 | May 8, 2024 | Form 4 ↗ |
| Cormorant Asset Management, LP10% owner | Purchase | +642.8K | $11.70 | $7.5M | 8.1Mindirect | May 6, 2024 | May 8, 2024 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +186.5K | $18.90 | $3.5M | 7.5Mindirect | Apr 18, 2024 | Apr 22, 2024 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +395.2K | $17.62 | $7.0M | 7.3Mindirect | Apr 18, 2024 | Apr 22, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −209 | $28.49 | $6K | 38.0Kdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −33.7K | $25.77 | $868K | 36.5Kdirect | Jan 26, 2024 | Jan 30, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −15.6K | $25.41 | $397K | 70.2Kdirect | Jan 26, 2024 | Jan 30, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −51 | $25.41 | $1K | 85.8Kdirect | Jan 26, 2024 | Jan 30, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −9,604 | $25.27 | $243K | 38.0Kdirect | Jan 26, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −16.4K | $25.45 | $418K | 47.6Kdirect | Jan 26, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −300 | $25.00 | $8K | 36.5Kdirect | Jan 25, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −300 | $25.00 | $8K | 36.8Kdirect | Jan 25, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −300 | $25.00 | $8K | 38.0Kdirect | Jan 25, 2024 | Jan 26, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −300 | $25.00 | $8K | 38.3Kdirect | Jan 25, 2024 | Jan 26, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −5,600 | $25.01 | $140K | 38.0Kdirect | Jan 24, 2024 | Jan 26, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −5,700 | $25.01 | $143K | 43.6Kdirect | Jan 24, 2024 | Jan 26, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −5,651 | $25.02 | $141K | 36.5Kdirect | Jan 24, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −5,600 | $25.01 | $140K | 42.2Kdirect | Jan 24, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Lurker NancyExecutive Vice Chair · Director | Sale | −30.0K | $24.98 | $748K | 135.4Kdirect | Jan 24, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −3,096 | $25.00 | $77K | 36.5Kdirect | Jan 23, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −2,039 | $25.00 | $51K | 39.6Kdirect | Jan 23, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Lurker NancyExecutive Vice Chair · Director | Sale | −5,044 | $24.97 | $126K | 165.4Kdirect | Jan 23, 2024 | Jan 25, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −500 | $25.00 | $13K | 38.0Kdirect | Jan 23, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −400 | $25.00 | $10K | 38.5Kdirect | Jan 23, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −28.8K | $22.69 | $652K | 38.0Kdirect | Jan 22, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Jones David ScottSVP & Chief Commercial Officer | Sale | −5,416 | $22.24 | $120K | 66.7Kdirect | Jan 22, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Liu YeDirector | Sale | −1.9M | $19.45 | $37.2M | 100.2Kindirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Cormorant Asset Management, LP10% owner | Purchase | +750.0K | $19.75 | $14.8M | 6.9Mindirect | Jan 11, 2024 | Jan 11, 2024 | Form 4 ↗ |
| Cormorant Asset Management, LP10% owner | Purchase | +105.0K | $21.32 | $2.2M | 6.1Mindirect | Jan 9, 2024 | Jan 11, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −22.9K | $21.13 | $484K | 36.5Kdirect | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −1,458 | $20.00 | $29K | 25.7Kdirect | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Cormorant Asset Management, LP10% owner | Purchase | +588.2K | n/c | — | 6.0Mindirect | Dec 8, 2023 | Dec 12, 2023 | Form 4 ↗ |
| Liu YeDirector | Sale | −266.2K | $18.41 | $4.9M | 2.0Mindirect | Dec 6, 2023 | Dec 7, 2023 | Form 4 ↗ |
| Liu YeDirector | Sale | −733.8K | $19.91 | $14.6M | 2.3Mindirect | Dec 5, 2023 | Dec 7, 2023 | Form 4 ↗ |
| Pine Michael CraigChief Corp Dev.&Strat. Officer | Sale Amended | −1,000 | $20.79 | $21K | 4,343direct | Dec 4, 2023 | Dec 11, 2023 | Form 4 ↗ |
| Pine Michael CraigChief Corp Dev.&Strat. Officer | Sale Amended | −45.0K | $22.00 | $990K | 5,343direct | Dec 4, 2023 | Dec 11, 2023 | Form 4 ↗ |
| Pine Michael CraigChief Corp Dev.&Strat. Officer | Sale | −45.0K | $22.00 | $990K | 5,343direct | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Paggiarino Dario A.Chief Medical Officer | Sale | −30.6K | $22.00 | $674K | 25.7Kdirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Lurker NancyExecutive Vice Chair · Director | Sale | −20.0K | $20.76 | $415K | 170.6Kdirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +8,260 | n/c | — | 5.5Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +19.9K | n/c | — | 5.4Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +41.8K | n/c | — | 5.4Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +86.7K | n/c | — | 5.4Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +15.6K | n/c | — | 5.3Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +18.6K | n/c | — | 5.3Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +8,168 | n/c | — | 5.3Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +27.4K | n/c | — | 5.3Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +53.1K | n/c | — | 5.2Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +65.1K | n/c | — | 5.2Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +39.9K | n/c | — | 5.1Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +37.1K | $24.01 | $890K | 5.1Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +28.1K | $22.80 | $640K | 5.0Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +79.8K | $21.87 | $1.7M | 5.0Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +122.6K | $20.62 | $2.5M | 4.9Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +945.7K | $19.88 | $18.8M | 4.8Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Cormorant Global Healthcare Master Fund, LP10% owner | Purchase | +321.3K | $18.80 | $6.0M | 3.9Mindirect | Dec 4, 2023 | Dec 6, 2023 | Form 4 ↗ |
| EW Healthcare Partners-A, L.P.10% owner | Sale Amended | −20.0K | $9.90 | $198K | 3.5Mindirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| EW Healthcare Partners, L.P.10% owner | Sale | −20.0K | $9.90 | $198K | 3.5Mindirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −7,017 | $11.02 | $77K | 3.5Mindirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −71.5K | $10.17 | $727K | 3.5Mindirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −327 | $11.36 | $4K | 3.6Mindirect | Aug 30, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −60.6K | $10.92 | $662K | 3.6Mindirect | Aug 30, 2023 | Sep 1, 2023 | Form 4 ↗ |
| EW Healthcare Partners, L.P.10% owner | Sale | −565 | $11.56 | $7K | 3.7Mindirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| EW Healthcare Partners, L.P.10% owner | Sale | −87.3K | $10.74 | $937K | 3.7Mindirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| EW Healthcare Partners, L.P.10% owner | Sale | −60.9K | $11.71 | $713K | 3.7Mindirect | Aug 28, 2023 | Aug 30, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale Amended | −11.7K | $10.45 | $123K | 3.8Mindirect | Aug 25, 2023 | Aug 30, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale Amended | −72.9K | $11.09 | $809K | 3.8Mindirect | Aug 25, 2023 | Aug 30, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −54.7K | $11.19 | $612K | 3.8Mindirect | Aug 25, 2023 | Aug 28, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −30.0K | $10.67 | $320K | 3.9Mindirect | Aug 25, 2023 | Aug 28, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale Amended | −52.2K | $10.56 | $551K | 3.9Mindirect | Aug 24, 2023 | Aug 30, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale Amended | −87.1K | $11.54 | $1.0M | 3.9Mindirect | Aug 24, 2023 | Aug 30, 2023 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Sale | −139.3K | $14.62 | $2.0M | 3.9Mindirect | Aug 24, 2023 | Aug 28, 2023 | Form 4 ↗ |
| EW Healthcare Partners-A, L.P.10% owner | Sale | −121.1K | $13.05 | $1.6M | 4.0Mindirect | Aug 23, 2023 | Aug 24, 2023 | Form 4 ↗ |
| EW Healthcare Partners-A, L.P.10% owner | Sale | −46.8K | $14.62 | $684K | 4.1Mindirect | Aug 22, 2023 | Aug 24, 2023 | Form 4 ↗ |
| Liu YeDirector | Sale | −1 | $6.00 | $6 | 3.0Mindirect | May 30, 2023 | May 31, 2023 | Form 4 ↗ |
| Pine Michael CraigChief Corp Dev.&Strat. Officer | Purchase | +1,000 | $12.21 | $12K | 1,000direct | Mar 14, 2022 | Mar 15, 2022 | Form 4 ↗ |
| Lurker NancyPresident & CEO · Director | Sale | −10.0K | $20.15 | $202K | 103.5Kdirect | Nov 15, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Purchase | +10.0K | $0.48 | $5K | 40.0Kdirect | Sep 4, 2020 | Sep 9, 2020 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Purchase | +10.0K | $0.61 | $6K | 30.0Kdirect | Aug 24, 2020 | Aug 26, 2020 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Purchase | +10.0K | $0.96 | $10K | 20.0Kdirect | Mar 12, 2020 | Mar 13, 2020 | Form 4 ↗ |
| Lurker NancyPresident & CEO · Director | Purchase | +98.0K | $1.06 | $104K | 574.8Kdirect | Mar 10, 2020 | Mar 11, 2020 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Purchase | +10.0K | $1.43 | $14K | 10.0Kdirect | Nov 15, 2019 | Nov 18, 2019 | Form 4 ↗ |
| Landis John B.Director | Purchase | +40.0K | $1.74 | $70K | 40.0Kdirect | May 13, 2019 | May 15, 2019 | Form 4 ↗ |
| Duker Jay S.Director | Purchase | +5,000 | $1.89 | $9K | 17.5Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Lurker NancyPresident & CEO · Director | Purchase | +28.5K | $1.76 | $50K | 240.2Kdirect | Mar 29, 2019 | Apr 1, 2019 | Form 4 ↗ |
| Godshall Douglas EvanDirector | Purchase | +17.0K | $1.75 | $30K | 29.5Kdirect | Mar 29, 2019 | Apr 1, 2019 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Purchase | +652.2K | n/c | — | 25.5Mindirect | Jun 25, 2018 | Jul 3, 2018 | Form 4 ↗ |
| Essex Woodlands IX, LLC10% owner | Purchase | +16.2M | n/c | — | 25.5Mdirect | Jun 25, 2018 | Jul 3, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Sep 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →
